menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Startup News

>

Ready-made...
source image

TechCrunch

5d

read

100

img
dot

Image Credit: TechCrunch

Ready-made stem cell therapies for pets could be coming

  • San Diego startup Gallant has secured $18 million in funding to develop the first FDA-approved ready-to-use stem cell therapy for veterinary medicine.
  • The therapy aims to address conditions in pets like Feline Chronic Gingivostomatitis (FCGS) and arthritis, with promising early results showing improvements in pain and mobility.
  • Gallant's approach differentiates itself by utilizing ready-to-use cells from donor animals, potentially simplifying the treatment process compared to traditional stem cell therapies.
  • Investors, including Digitalis Ventures and NovaQuest Capital Management, are optimistic about Gallant's potential, recognizing its novel approach and convenience.

Read Full Article

like

5 Likes

For uninterrupted reading, download the app